Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark
Guardion Health Sciences, Inc. (GHSI)
Company Research
Source: GlobeNewswire
The Only Computer Vision Testing Device to Combine Standardized Contrast Sensitivity Testing with a Full Suite of Clinical Vision Tests San Diego, California, July 15, 2020 (GLOBE NEWSWIRE) -- VectorVision®, a wholly-owned subsidiary of Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a specialty health sciences company that develops medical foods and medical devices in the ocular health marketplace and which is developing nutraceuticals it believes will provide medicinal and health benefits to consumers, announced that it has received approval from the Korean Intellectual Property Office in accordance with the Korean Trademark Act to trademark the CSV-2000. The Korean Intellectual Property Office is the national patent and intellectual property office of South Korea. VectorVision’s CSV-2000 is the first and only computer vision testing device that provides for standardized contrast sensitivity testing, along with the full range of visual acuity, color,
Show less
Read more
Impact Snapshot
Event Time:
GHSI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GHSI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GHSI alerts
High impacting Guardion Health Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GHSI
News
- Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching [Yahoo! Finance]Yahoo! Finance
- Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 [Yahoo! Finance]Yahoo! Finance
- Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023GlobeNewswire
- Guardion Health Sciences, Inc. (NASDAQ: GHSI) had its "hold" rating re-affirmed by analysts at Maxim Group.MarketBeat
- Thinking about buying stock in Guardion Health Sciences, Minim, Revelation Biosciences, Nyxoah, or Pixelworks?PR Newswire
GHSI
Sec Filings
- 4/9/24 - Form 8-K
- 4/8/24 - Form DEFM14A
- 4/3/24 - Form 3
- GHSI's page on the SEC website